Evidence has been presented that the plasma concentration ratio of triglyceride (TG)/HDL-cholesterol (HDL-C) may provide a relatively simple way to identify apparently healthy insulin-resistant persons with increased cardiometabolic risk ( 1, 2 ). However, there is evidence that the actual values of the ratio that best identifi es such individuals will vary as a function of racial/ethnic background ( 3-7 ). More recently, it has also been shown that the most useful TG/ HDL-C cut-point to identify cardiometabolic risk is not the same in men and women ( 2 ). However, there is essentially no information as to whether age also modifi es the ability of the TG/HDL-C ratio to identify apparently healthy individuals with increased cardiometabolic risk. The primary goal of this analysis was to address this issue, and it is based on data obtained in an apparently healthy population of young men and women, mean age of 19 years. Second, since the diagnostic category of the metabolic syndrome (MetS) is commonly used to identify cardiometabolic risk in apparently healthy individuals ( 3, 8 ), our second goal was to compare these two approaches to identify insulin resistance (IR) and associated cardiometabolic risk in a population of young adults . In support of this effort is the recent observation that the plasma concentration ratio of TG/HDL-C was an independent determinant of arterial stiffness in adolescents and young adults ( 9 ).
(QUICKI); SBP and DBP; body mass index (BMI); WC; and glucose, HDL-C, and TG concentrations were compared between this quartile and the remaining three quartiles.
HOMA-IR ( 11 ) and QUICKI ( 12 ) were used as surrogate estimates of insulin resistance, and the quartile with the highest value was defi ned as being insulin resistant, a classifi cation based on results of a prospective study ( 13 ) . The sensitivity and specifi city of the TG/HDL-C ratio and the MetS to identify insulin resistance were calculated using as cut-points the values that separated the upper 25% of the TG/HDL-C ratio or a diagnosis of the MetS.
Criteria for diagnosing the MetS are those outlined in the "harmonized" version of the ATP III and IDF, in which at least three of the following fi ve criteria must be satisfi ed ( 8 ) : 1 ) WC у 90 cm in men and у 80 cm in women; 2 ) HDL-C < 40 mg/dl in men and < 50 mg/dl in women; 3 ) TG у 150 mg/dl; 4 ) SBP у 130 mmHg or DBP у 85 mmHg; 5 ) glucose у 100 mg/dl and < 126 mg/dl.
Statistical analysis
The mean and SD were calculated separately in women and men for each experimental variable measured, and Student's t test was used to compare cardiometabolic risk factors. A cardiometabolic risk profi le was generated by calculating the mean and SD of each measurement, dividing the men and women into two groups, stratifi ed into those whose TG/HDL-C concentration ratio was in the upper quartile versus the lower 75%, and those who did or did not meet diagnostic criteria for the MetS.
The sensitivity and specifi city ( 14 ) with which either the elevated TG/HDL-C ratio or the MetS identifi ed the 25% of the population who were insulin resistant, as defi ned by HOMA-IR and QUICKI, were determined ( 15 ). Student's t test was performed using the R statistical language ( 16 ) .
RESULTS
Demographic and metabolic characteristics of the study population are presented in Table 1 . Note that every risk factor was accentuated in men. Table 1 also provides an estimate of the prevalence of conventional cardiometabolic risk factors in this young student population. Although only approximately 10% were obese by BMI criteria, the incidence of abdominal obesity was substantial, particularly
Participants
The study sample included 2,244 fi rst-year university students (1,545 women and 699 men), 17-24 years of age, from the Méx-ico City metropolitan area. Data were obtained by the Multidisciplinary Group to Investigate Health and Academic Performance (GMISARA) of the Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México (UNAM) ( 10 ) . GMISARA employed a complex, multistage, geographic-area design for collecting data from public universities in the metropolitan area (UNAM and Universidad Autónoma de la Ciudad de México, UACM). All students were informed about the study, and they signed an informed consent. The protocol was approved by the Institutional Ethics Committee, and samples were collected over four years (2009) (2010) (2011) (2012) . Participants were not aware of any disease by medical history, nor did physical examination reveal any disease of relevance to this study. GMISARA members were trained to conduct interviews for collecting reliable data, including demographic, socioeconomic, dietary, and health-related information. Medical and physiological measurements were performed and collected by GMISARA medical personnel, and laboratory measurements were performed by CARPERMOR, S.A. de C.V., an internationally certifi ed laboratory.
Study design
Measurement of cardiometabolic risk factors. Students fasted overnight and were seen at either UNAM or UACM between 7 AM and 10 AM. Waist circumference (WC) was determined while participants were upright, and it was measured to the nearest 0.1 cm at minimal respiration following normal expiration, with a fl exible measuring tape placed at the high point of the iliac crest. Diastolic blood pressure (DBP) and systolic blood pressure (SBP) values were obtained after participants were resting quietly in a sitting position for 5 min, and determination of the maximum infl ation level (up to four consecutive blood pressure readings) was obtained with a standard aneroid sphygmomanometer (Model DS44, Welch Allyn). The maximum values of replicate systolic and diastolic measurements provided estimates of blood pressure values. Glucose, insulin, TG, and HDL-C concentrations were determined by standard methods (CARPERMOR, S.A. de C.V.).
Criteria for subject classifi cation. Men and women were divided into quartiles on the basis of their TG/HDL-C concentration ratios, and mean ± SD values were calculated. The 25% of the population with the highest TG/HDL-C ratio was defi ned as "abnormal," and values for age, homeostasis model assessment -insulin resistance (HOMA-IR); quantitative insulin sensitivity check index TG/HDL-C ratio having greater sensitivity but decreased specifi city. These general fi ndings were similar, irrespective of the use of HOMA-IR or QUICKI as the estimate of insulin resistance.
Tables 4 and 5 compare the cardiometabolic risk profi les of subjects identifi ed because they had an abnormal TG/HDL-C ratio, versus those with a normal ratio, as well as those with and without the MetS. Focusing initially on the TG/HDL-C ratio, with the exception of age, all of the risk factors measured were signifi cantly accentuated in those women (>2.5, Table 4 ) or men (>3.5, Table 5 ) with an abnormal ratio. Essentially identical results were seen when the cardiometabolic risk factors of those individuals, identifi ed as the result of a diagnosis of the MetS, were compared with those without the MetS ( Tables 4 and 5 ) .
In this context, although an abnormal TG/HDL-C ratio was more common than the MetS in both women (463 versus 196) and men (173 versus 102), the magnitude of the difference between individuals with the MetS compared with those who did not meet the diagnostic criteria was greater than the differences between those with an abnormal or normal TG/HDL-C ratio. Since a signifi cant number of women with an abnormal TG/HDL-C ratio also had the MetS (n = 168 out of 463; 36%) as did men (n = 83 out of 173; 48%), it did not seem appropriate to assign statistical signifi cance to the magnitude of these differences in cardiometabolic risk factors, as a function of which criteria was used to identify the population. On the other hand, it seemed worthwhile to draw attention to these data. It is also of interest to note that relatively few in the women. Blood pressure was higher in the men, as was the prevalence of prediabetes (fasting glucose у 100 mg/dl). Undiagnosed type 2 diabetes was limited to three men and one woman. The most prevalent abnormalities were high TG and low HDL-C concentrations, the former common in men and the latter in women.
The TG/HDL-C concentration ratios that marked the separation of the 25% of the participants with the highest ratios were у 2.43 and у 3.48 in women and men, respectively. Based upon these fi ndings, TG/HDL-C concentration ratios of у 3.5 (men) and у 2.5 (women) were classifi ed as "abnormal." Table 2 presents the prevalence of IR in women and men who have either an abnormal TG/HDL-C or the MetS. When using HOMA-IR as the estimate of insulin action, the percentage of IR was greater in women who were identifi ed by an abnormal TG/HDL-C ratio (n = 188, 12.2%) rather than the MetS (n = 129, 8.3%). The results in men were qualitatively comparable (13.4% versus 11.3%). The results were essentially identical when QUICKI was used as the estimate of IR. Thus, IR was more common when identifi ed with the TG/HDL-C ratio than with MetS criteria, irrespective of which estimate of insulin resistance was used.
A more formal analysis of the ability of the two different criteria to identify insulin-resistant individuals is shown in Table 3 . In women, the sensitivity of the TG/HDL-C ratio was greater in identifying insulin-resistant individuals than was the MetS, whereas the MetS had greater specifi city. The same general observation held true in men, with the For TG/HDL-C, low р 2.5 women, р 3.5 men; for TG/HDL-C high > 2.5 women, > 3.5 men. For IR-no, HOMA-IR р 2.9 women, р 2.5 men; QUICKI > 0.3265 women, > 0.3329 men; for IR-yes, HOMA-IR > 2.9 women, > 2.5 men, QUICKI р 0.3265 women, р 0.3329 men. Mexican-Americans ( 7 ). Furthermore, the TG/HDL-C ratio has been associated with IR in white obese teenagers and could be used along with other risk factors to identify subjects at increased risk of the appearance of IR-related morbidity ( 17 ) .
TABLE 3. Sensitivity and specifi city with which TG/HDL-C ratio and MetS identify IR individuals
On the other hand, the pragmatic use of the results of this study is not as clear and, to a large extent, depends upon the issue being pursued. For example, the sensitivity and specifi city with which the TG/HDL-C ratio and the MetS identifi ed insulin-resistant young individuals of Mexican-Mestizo origin was remarkably similar to values found in previous studies of middle-aged men and women of European ancestry ( 2, 15, 18, 19 ) . Neither the TG/HDL-C ratio nor the MetS criteria identify IR individuals with great sensitivity, but both show reasonable specifi city. Since the sensitivity and specifi city of the two approaches to identify insulin-resistant individuals are comparable, use of the TG/HDL-C would cast a larger net than the MetS if the goal was to maximize the potential number of IR individuals to be captured.
However, if severity of the cardiometabolic risk factor profi le is the goal, the MetS appeared to accomplish this task more effectively in this group of young college students. Thus, although both approaches demonstrated that the cardiometabolic risk profi le was signifi cantly accentuated in women (2%) and men (3%) with a normal TG/HDL-C ratio had the MetS.
DISCUSSION
Several straightforward conclusions can be drawn from the results of this study. First, the data are consistent with earlier fi ndings ( 15 ) that showed that the cut-points that separated the 25% individuals with the highest TG/HDL-C concentration ratio from the rest of the population were different in women than in men. Second, and perhaps surprisingly, the cut-points that identifi ed the 25% of the college-aged women and men with the highest TG/HDL-C concentration ratios in this study were essentially identical to those reported in a group of middle-aged (mean age ‫ف‬ 50 years) men and women ( 15 ) . Third, in addition to being younger, the TG/HDL-C cut-points obtained in this study were established in a population primarily of Mexican Mestizo ancestry compared with a population with European ancestry ( 15 ) . This latter fi nding is of interest in that the association of the TG/HDL-C ratio with fasting plasma insulin concentration was similar in non-Hispanic whites and 38.4 ± 6.9 ** 47.6 ± 9.1 38.2 ± 7.9 ** TG/HDL-C ratio 2.0 ± 0.7 5.9 ± 3.1 ** 2.5 ± 1.5 6.0 ± 3.8 **
Assessed by the TG/HDL-C ratio versus MetS. * P < 0.05; ** P < 0.001.
by guest, on October 14, 2017 www.jlr.org Downloaded from the "abnormal" subset (the 25% with the highest TG/HDL-C ratio or the MetS), the results in Tables 4 and 5 suggest that the magnitude of difference between the "high-risk" group and the remainder was magnifi ed when identifi ed by the MetS. The strengths of this study are that, for the fi rst time, the potential utility of the TG/HDL-C ratio to identify apparently healthy individuals who are insulin resistant and at enhanced cardiometabolic risk was evaluated in collegeaged students of Mexican-Mestizo origin rather than a middle-aged population of European ancestry. In addition, the fi ndings were obtained from a reasonably large population (n = 2,244). The obvious weakness is the absence of any outcome data. However, despite these shortcomings, we would argue that our results are of interest in that values of the TG/HDL-C ratio separating the 25% of college-aged men and women with the highest ratios from the remainder of the experimental population were essentially identical to those reported in middle-aged men and women ( 2, 15, 18, 19 ) . Furthermore, this was the case despite the substantial racial/ethnic differences (European versus Mexican-Mestizo ancestry) in this study compared with earlier ones. Both the TG/HDL-C cut-points and a diagnosis of MetS were able to identify IR individuals, whose associated cardiometabolic risk profi le was signifi cantly more adverse than the remainder of the population. However, the two approaches differed in that the TG/HDL-C ratio identifi ed a greater number of "highrisk" subjects, consistent with fi ndings in white obese teenagers ( 17 ) , whereas the MetS criteria seemed to fi nd a group whose cardiometabolic risk profi le was somewhat accentuated.
In conclusion, the results of this study show that TG/ HDL-C cut-points based on fi ndings in middle-aged men and women of European ancestry can identify apparently healthy Mexican-Mestizo individuals who are insulin resistant and at increased cardiometabolic risk. In addition, data were presented comparing the relative abilities of the TG/HDL-C ratio and the MetS to accomplish these tasks. Given this information, the individual clinician/investigator can use the approach that seems most relevant to their clinical/research interests.
